Shi Jieliang, Tu Yunhai, Xu Mingna, Wu Wencan
Department of Orbital and Oculoplastic Surgery, Eye Hospital of Wenzhou Medical University, Wenzhou, China.
Front Oncol. 2022 Oct 14;12:975637. doi: 10.3389/fonc.2022.975637. eCollection 2022.
Surgical treatment of optic nerve tumors is challenging. The study's objective was to evaluate the efficacy of a combined endoscopic transethmoid and transconjunctival approach in patients without functional vision.
A retrospective, noncomparative case series.
Retrospective data were collected from all patients who had undergone tumor resection using this approach at the authors' institution between 2015 and 2021. Preoperative assessments included magnetic resonance imaging and ophthalmological examinations, and re-assessments were conducted three months after surgery and regularly during the follow-up period.
Seventeen patients, mean age 35 ± 19.0 years, were enrolled. Of these, 64.7% presented with visual acuity (VA) of light perception or no light perception. Gross total resection was realized in all patients. The average decline in exophthalmos was 3.63 ± 1.93 mm. Tumor histopathological analysis identified 12 optic nerve sheath meningiomas and 5 optic gliomas. The mean follow-up time was 30 months during which there was no local recurrence in any of the patients.
The combined endoscopic transethmoid and transconjunctival approach offers an additional choice for accessing optic nerve tumors. The procedure is both safe and effective and provides an alternative transcranial route to the orbit.
视神经肿瘤的手术治疗具有挑战性。本研究的目的是评估联合鼻内镜经筛窦和经结膜入路对无功能性视力患者的疗效。
一项回顾性、非对照病例系列研究。
收集2015年至2021年期间在作者所在机构采用该入路进行肿瘤切除的所有患者的回顾性数据。术前评估包括磁共振成像和眼科检查,术后三个月及随访期间定期进行重新评估。
共纳入17例患者,平均年龄35±19.0岁。其中,64.7%的患者视力为光感或无光感。所有患者均实现了肿瘤全切。眼球突出平均下降3.63±1.93mm。肿瘤组织病理学分析确定12例视神经鞘膜瘤和5例视神经胶质瘤。平均随访时间为30个月,期间所有患者均无局部复发。
联合鼻内镜经筛窦和经结膜入路为视神经肿瘤的治疗提供了一种新的选择。该手术安全有效,为经颅入眶提供了一种替代方法。